Govindaraj Saravanan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Govindaraj Saravanan has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Panneerselvam Theivendren
Department of Pharmaceutical Chemistry & Analysis, School of Pharmaceutical Sciences, Vels Institute of Science, Technology & Advanced Studies, Pallavaram, Chennai, Tamil Nadu 600117, India
8 shared publications - Selvaraj Kunjiappan
Department of Biotechnology, Alliance University, Anekal, Bengaluru 562106, Karnataka, India
8 shared publications Veerachamy Alagarsamy
Department of Pharmaceutical Chemistry, MNR College of Pharmacy, Sangareddy, Telangana, India
7 shared publicationsChinnasamy Rajaram Prakash
6 shared publications- Parasuraman Pavadai
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, M.S. Ramaiah University of Applied Sciences, Bengaluru, India
5 shared publications Balasubramanian Somasundaram
Sir CV Raman‐KS Krishnan International Research Center Kalasalingam Academy of Research and Education Krishnankoil Tamil Nadu India
3 shared publications
Latest Publications
- 27 March 2026
- Published by Bentham Science Publishers Ltd. in Current Drug Therapy
- Vol. 21, 1-17
Cinnoline Derivatives in Breast Cancer Therapy: A Comprehensive Review of Their Therapeutic Potential
Breast cancer remains a major global health concern, contributing substantially to cancer-related morbidity and mortality among women. Despite advances in treatment, challenges such as drug resistance, systemic toxicity, and disease recurrence highlight the need for novel therapeutic agents. Cinnoline derivatives have emerged as promising anti-cancer compounds due to their diverse pharmacological properties. These heterocyclic molecules exert potent antiproliferative effects through multiple mechanisms, including induction of apoptosis, cell cycle arrest, and inhibition of oncogenic signaling pathways such as PI3K/Akt/mTOR and MAPK. Moreover, cinnoline derivatives show potential in overcoming drug resistance by modulat-ing efflux transporters and targeting cancer stem cells. Their pharmacokinetic profile—including absorption, distribution, metabolism, and excretion (ADME)—critically influ-ences clinical viability. Challenges such as poor solubility, rapid metabolism, and ineffi-cient absorption limit oral bioavailability, while lipophilicity and CYP450-mediated me-tabolism affect drug half-life, clearance, and overall therapeutic performance. Recent advancements in drug delivery strategies have improved the bioavailability and therapeutic index of cinnoline derivatives. Nanocarrier-based systems, including liposomes and polymeric nanoparticles, enable targeted delivery, minimizing systemic toxicity while enhancing efficacy. Additionally, cinnoline derivatives have demonstrated synergistic ef-fects when combined with conventional chemotherapeutics, immunotherapies, and hor-mone-based treatments, providing promising avenues for combination therapy. Nevertheless, optimizing pharmacokinetics, reducing off-target toxicity, and ensuring clin-ical translation remain significant challenges. Future research should focus on structural modifications, personalized medicine approaches, and rigorous preclinical and clinical evaluations to validate safety and efficacy. Overall, cinnoline derivatives hold substantial potential to revolutionize breast cancer therapy, offering more precise, effective, and well-tolerated treatment options.
- 27 March 2026
- Published by Bentham Science Publishers Ltd. in Current Drug Therapy
- Vol. 21, 1-17
Cinnoline Derivatives in Breast Cancer Therapy: A Comprehensive Review of Their Therapeutic Potential
Breast cancer remains a major global health concern, contributing substantially to cancer-related morbidity and mortality among women. Despite advances in treatment, challenges such as drug resistance, systemic toxicity, and disease recurrence highlight the need for novel therapeutic agents. Cinnoline derivatives have emerged as promising anti-cancer compounds due to their diverse pharmacological properties. These heterocyclic molecules exert potent antiproliferative effects through multiple mechanisms, including induction of apoptosis, cell cycle arrest, and inhibition of oncogenic signaling pathways such as PI3K/Akt/mTOR and MAPK. Moreover, cinnoline derivatives show potential in overcoming drug resistance by modulat-ing efflux transporters and targeting cancer stem cells. Their pharmacokinetic profile—including absorption, distribution, metabolism, and excretion (ADME)—critically influ-ences clinical viability. Challenges such as poor solubility, rapid metabolism, and ineffi-cient absorption limit oral bioavailability, while lipophilicity and CYP450-mediated me-tabolism affect drug half-life, clearance, and overall therapeutic performance. Recent advancements in drug delivery strategies have improved the bioavailability and therapeutic index of cinnoline derivatives. Nanocarrier-based systems, including liposomes and polymeric nanoparticles, enable targeted delivery, minimizing systemic toxicity while enhancing efficacy. Additionally, cinnoline derivatives have demonstrated synergistic ef-fects when combined with conventional chemotherapeutics, immunotherapies, and hor-mone-based treatments, providing promising avenues for combination therapy. Nevertheless, optimizing pharmacokinetics, reducing off-target toxicity, and ensuring clin-ical translation remain significant challenges. Future research should focus on structural modifications, personalized medicine approaches, and rigorous preclinical and clinical evaluations to validate safety and efficacy. Overall, cinnoline derivatives hold substantial potential to revolutionize breast cancer therapy, offering more precise, effective, and well-tolerated treatment options.
- Open Access
- 25 July 2025
- Published by Taylor & Francis in Essential Chem
- Vol. 2 (1)
Targeting TACE in breast cancer: exploring the therapeutic potential of cinnoline derivatives through computational and experimental approaches
- 25 July 2025
- Published by Taylor & Francis in Essential Chem
- Vol. 2 (1)
Open AccessTargeting TACE in breast cancer: exploring the therapeutic potential of cinnoline derivatives through computational and experimental approaches
- 23 February 2021
- Published by Elsevier in Materials Today: Proceedings
WITHDRAWN: Performance analysis of acrylic material based prosthetic limb with EMG signal
- 23 February 2021
- Published by Elsevier in Materials Today: Proceedings
WITHDRAWN: Performance analysis of acrylic material based prosthetic limb with EMG signal
- Open Access
- 25 February 2020
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 32 (4) , 970-974
Synthesis, Characterization & Antimicrobial Activities of New Isoxazole Substituted Mannich and Schiff Bases of 5-Nitroisatin Analogs
A sequence of new isoxazole substituted Schiff base and Mannich base of 5-nitroisatin are synthesized by a multi-step synthesis from 5-nitroisatin. Whole synthesized analogs were characterized using IR, NMR, Mass spectroscopy and microanalyses. All the Schiff and Mannich bases were tested for their antimicrobial potencies against some human pathogenic microorganism using agar well diffusion technique. The relationship between the biological activity and the functional group variation of the Schiff and Mannich bases were analyzed. Standard ciprofloxacin and ketoconazole were used to compare the antimicrobial activities of novel isatin coupled isoxazole derivatives.
- 25 February 2020
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 32 (4) , 970-974
Open AccessSynthesis, Characterization & Antimicrobial Activities of New Isoxazole Substituted Mannich and Schiff Bases of 5-Nitroisatin Analogs
A sequence of new isoxazole substituted Schiff base and Mannich base of 5-nitroisatin are synthesized by a multi-step synthesis from 5-nitroisatin. Whole synthesized analogs were characterized using IR, NMR, Mass spectroscopy and microanalyses. All the Schiff and Mannich bases were tested for their antimicrobial potencies against some human pathogenic microorganism using agar well diffusion technique. The relationship between the biological activity and the functional group variation of the Schiff and Mannich bases were analyzed. Standard ciprofloxacin and ketoconazole were used to compare the antimicrobial activities of novel isatin coupled isoxazole derivatives.
- 14 November 2019
- Published by Springer Nature in Journal of the Iranian Chemical Society
- Vol. 17 (4) , 789-801
Optimization and analysis of ultrasound-assisted extraction of bioactive polyphenols from Garcinia indica using RSM and ANFIS modeling and its anticancer activity
- 14 November 2019
- Published by Springer Nature in Journal of the Iranian Chemical Society
- Vol. 17 (4) , 789-801
Optimization and analysis of ultrasound-assisted extraction of bioactive polyphenols from Garcinia indica using RSM and ANFIS modeling and its anticancer activity
- 8 September 2019
- Published by Wiley in Biotechnology Progress
- Vol. 36 (1) , e2904
Design and in silico modeling of Indoloquinoxaline incorporated keratin nanoparticles for modulation of glucose metabolism in 3T3‐L1 adipocytes
The following study was done to assess the glucose utilizing efficiency of Indoloquinoxaline derivative incorporated keratin nanoparticles (NPs) in 3T3‐L1 adipocytes. Indoloquinoxaline derivative had wide range of biological activities including antidiabetic activity. In this view, Indoloquinoxaline moiety containing N , N ‐dimethyl (3‐fluoro‐6H‐indolo [3,2‐b] quinoxalin‐6‐yl) methanamine compound was designed and synthesized, and further it is incorporated into keratin nanoparticles. The formulated NPs, drug entrapment efficiency, releasing capacity, stability, and physicochemical properties were characterized by various spectral analyzer and obtained results of characterizations were confirmed the properties of NPs. The analysis of mechanism underlying the glucose utilization of NPs was examined through molecular docking with identified target, and observed in silico study reports shown strong interaction of NPs in the binding pockets of AMPK and PTP1B. Based on the in silico screening, the formulated NPs was performed for in vitro cellular viability and glucose uptake studies on 3T3‐L1 adipocytes. Interestingly, 40 μg of NPs displayed 78.2 ± 2.76% cellular viability, and no cell death was observed at lower concentrations. Further, the concentration dependent glucose utilization was observed at different concentrations of NPs in 3T3‐L1 adipocytes. The results of NPs (40 μg) on glucose utilization have revealed eminent result 58.56 ± 4.54% compared to that of Metformin (10 μM) and Insulin (10 μM). The identified results clearly indicated that Indoloquinoxaline derivative incorporated keratin NPs significantly increased glucose utilization efficiency and protect the cells against the insulin resistance.
- 8 September 2019
- Published by Wiley in Biotechnology Progress
- Vol. 36 (1) , e2904
Design and in silico modeling of Indoloquinoxaline incorporated keratin nanoparticles for modulation of glucose metabolism in 3T3‐L1 adipocytes
The following study was done to assess the glucose utilizing efficiency of Indoloquinoxaline derivative incorporated keratin nanoparticles (NPs) in 3T3‐L1 adipocytes. Indoloquinoxaline derivative had wide range of biological activities including antidiabetic activity. In this view, Indoloquinoxaline moiety containing N , N ‐dimethyl (3‐fluoro‐6H‐indolo [3,2‐b] quinoxalin‐6‐yl) methanamine compound was designed and synthesized, and further it is incorporated into keratin nanoparticles. The formulated NPs, drug entrapment efficiency, releasing capacity, stability, and physicochemical properties were characterized by various spectral analyzer and obtained results of characterizations were confirmed the properties of NPs. The analysis of mechanism underlying the glucose utilization of NPs was examined through molecular docking with identified target, and observed in silico study reports shown strong interaction of NPs in the binding pockets of AMPK and PTP1B. Based on the in silico screening, the formulated NPs was performed for in vitro cellular viability and glucose uptake studies on 3T3‐L1 adipocytes. Interestingly, 40 μg of NPs displayed 78.2 ± 2.76% cellular viability, and no cell death was observed at lower concentrations. Further, the concentration dependent glucose utilization was observed at different concentrations of NPs in 3T3‐L1 adipocytes. The results of NPs (40 μg) on glucose utilization have revealed eminent result 58.56 ± 4.54% compared to that of Metformin (10 μM) and Insulin (10 μM). The identified results clearly indicated that Indoloquinoxaline derivative incorporated keratin NPs significantly increased glucose utilization efficiency and protect the cells against the insulin resistance.
- 23 April 2019
- Published by Springer Nature in 3 Biotech
- Vol. 9 (5) , 1-20
Modeling a pH-sensitive Zein-co-acrylic acid hybrid hydrogels loaded 5-fluorouracil and rutin for enhanced anticancer efficacy by oral delivery
The combination of natural and synthetic polymeric materials grafted hydrogels offer great potential as oral therapeutic systems because of its intrinsic biocompatibility, biodegradability, protect labile drugs from metabolism and controlled release properties. Hence, in the present study, we aimed to prepare and optimize oral delivered pH-responsive Zein-co-acrylic acid hydrogels incorporated with 5-fluorouracil (5-Fu) and rutin (Ru) for effective anticancer activity with less toxicity. In this study, graft polymerization technique is adopted to formulate hydrogels with various ratios of Zein, acrylic acid, N, N-methylene bisacrylamide, and ammonium persulphate as an initiator. The optimized formulation was identified based on the cross-linking, chemical interactions, intrinsic viscosity (η), dynamic swelling (Q) at pH 1.2, diffusion coefficient (D), sol–gel fraction (%), and porosity (%). The selected optimized formulation has shown significant improvement in drugs loading and encapsulation efficiency, releasing at pH 1.2 and pH 7.4. Drug release kinetics studies confirmed the controlled release properties of hydrogels. Hydrogels were porous and the drug loading of 5-Fu and Ru was found to be 12.13% and 10.86%, respectively, whereas encapsulation efficiency of 5-Fu and Ru was 89.35% and 81.47%, respectively. Furthermore, form the in vitro cytotoxic screening, it was found that 52.5 µg mL−1 5-Fu and Ru-loaded hydrogel impacted 50% of cell death at 24 h, there by significantly arresting the proliferation of MDA-MB-231 and MCF-7 breast cancer cell lines. Altogether, the optimized pH-responsive hydrogels make them favorable carrier for anticancer drugs for oral delivery.
- 23 April 2019
- Published by Springer Nature in 3 Biotech
- Vol. 9 (5) , 1-20
Modeling a pH-sensitive Zein-co-acrylic acid hybrid hydrogels loaded 5-fluorouracil and rutin for enhanced anticancer efficacy by oral delivery
The combination of natural and synthetic polymeric materials grafted hydrogels offer great potential as oral therapeutic systems because of its intrinsic biocompatibility, biodegradability, protect labile drugs from metabolism and controlled release properties. Hence, in the present study, we aimed to prepare and optimize oral delivered pH-responsive Zein-co-acrylic acid hydrogels incorporated with 5-fluorouracil (5-Fu) and rutin (Ru) for effective anticancer activity with less toxicity. In this study, graft polymerization technique is adopted to formulate hydrogels with various ratios of Zein, acrylic acid, N, N-methylene bisacrylamide, and ammonium persulphate as an initiator. The optimized formulation was identified based on the cross-linking, chemical interactions, intrinsic viscosity (η), dynamic swelling (Q) at pH 1.2, diffusion coefficient (D), sol–gel fraction (%), and porosity (%). The selected optimized formulation has shown significant improvement in drugs loading and encapsulation efficiency, releasing at pH 1.2 and pH 7.4. Drug release kinetics studies confirmed the controlled release properties of hydrogels. Hydrogels were porous and the drug loading of 5-Fu and Ru was found to be 12.13% and 10.86%, respectively, whereas encapsulation efficiency of 5-Fu and Ru was 89.35% and 81.47%, respectively. Furthermore, form the in vitro cytotoxic screening, it was found that 52.5 µg mL−1 5-Fu and Ru-loaded hydrogel impacted 50% of cell death at 24 h, there by significantly arresting the proliferation of MDA-MB-231 and MCF-7 breast cancer cell lines. Altogether, the optimized pH-responsive hydrogels make them favorable carrier for anticancer drugs for oral delivery.
- 4 January 2019
- Published by Wiley in Drug Development Research
- Vol. 80 (3) , 368-385
Graph theoretical analysis, in silico modeling, prediction of toxicity, metabolism and synthesis of novel 2‐(methyl/phenyl)‐3‐(4‐(5‐substituted‐1,3,4‐oxadiazol‐2‐yl) phenyl) quinazolin‐4(3H)‐ones as NMDA receptor inhibitor
Hit, Lead & Candidate Discovery A variety of novel 2‐(methyl/phenyl)‐3‐(4‐(5‐substituted‐1,3,4‐oxadiazol‐2‐yl)phenyl) quinazolin‐4(3H)‐ones have been synthesized by treating 3‐(4‐(5‐mercapto‐1,3,4‐oxadiazol‐2‐yl)phenyl)‐2‐(methyl/phenyl)‐quinazolin‐4(3H)‐one with a variety of secondary amines. Graph theoretical analysis was used in identification of drug target that is, NMDAR (N‐methyl‐d‐aspartate receptors). The observed reports of in silico modeling and ligand based toxicity, metabolism prediction studies were encouraging us to synthesize of title compounds and evaluate their antiepileptic effects. The title compounds were tested for its antiepileptic potency by MES and scPTZ model. Rotorod test is used to assess its neurotoxicity. In the preliminary test it was found that in MES test, analogs 6d, 6e, 6f, and 6l were potent; whereas in scPTZ test analogs 6d, 6e, 6f, and 6k displayed potent antiepileptic activity. Additionally these five derivatives were tested in rats orally at a dose of 30 mg/kg and found that compounds 2‐methyl‐3‐(4‐(5‐morpholino‐1,3,4‐oxadiazol‐2‐yl)phenyl)quinazolin‐4(3H)‐one 6e and 2‐methyl‐3‐(4‐(5‐(piperidin‐1‐yl)‐1,3,4‐oxadiazol‐2‐yl)phenyl)quinazolin‐4(3H)‐one 6f exhibited superior activity than reference Phenytoin. In MES test, these derivatives 6e and 6f showed activity at 30 mg/kg i.p. dose after 0.5 hr and 4.0 hr. In scPTZ test these derivatives 6e and 6f showed activity at 100 and 300 mg/kg i.p. dose after 0.5 hr and 4.0 hr, respectively.
- 4 January 2019
- Published by Wiley in Drug Development Research
- Vol. 80 (3) , 368-385
Graph theoretical analysis, in silico modeling, prediction of toxicity, metabolism and synthesis of novel 2‐(methyl/phenyl)‐3‐(4‐(5‐substituted‐1,3,4‐oxadiazol‐2‐yl) phenyl) quinazolin‐4(3H)‐ones as NMDA receptor inhibitor
Hit, Lead & Candidate Discovery A variety of novel 2‐(methyl/phenyl)‐3‐(4‐(5‐substituted‐1,3,4‐oxadiazol‐2‐yl)phenyl) quinazolin‐4(3H)‐ones have been synthesized by treating 3‐(4‐(5‐mercapto‐1,3,4‐oxadiazol‐2‐yl)phenyl)‐2‐(methyl/phenyl)‐quinazolin‐4(3H)‐one with a variety of secondary amines. Graph theoretical analysis was used in identification of drug target that is, NMDAR (N‐methyl‐d‐aspartate receptors). The observed reports of in silico modeling and ligand based toxicity, metabolism prediction studies were encouraging us to synthesize of title compounds and evaluate their antiepileptic effects. The title compounds were tested for its antiepileptic potency by MES and scPTZ model. Rotorod test is used to assess its neurotoxicity. In the preliminary test it was found that in MES test, analogs 6d, 6e, 6f, and 6l were potent; whereas in scPTZ test analogs 6d, 6e, 6f, and 6k displayed potent antiepileptic activity. Additionally these five derivatives were tested in rats orally at a dose of 30 mg/kg and found that compounds 2‐methyl‐3‐(4‐(5‐morpholino‐1,3,4‐oxadiazol‐2‐yl)phenyl)quinazolin‐4(3H)‐one 6e and 2‐methyl‐3‐(4‐(5‐(piperidin‐1‐yl)‐1,3,4‐oxadiazol‐2‐yl)phenyl)quinazolin‐4(3H)‐one 6f exhibited superior activity than reference Phenytoin. In MES test, these derivatives 6e and 6f showed activity at 30 mg/kg i.p. dose after 0.5 hr and 4.0 hr. In scPTZ test these derivatives 6e and 6f showed activity at 100 and 300 mg/kg i.p. dose after 0.5 hr and 4.0 hr, respectively.
- 23 September 2018
- Published by Wiley in Drug Development Research
- Vol. 79 (6) , 260-274
Design, graph theoretical analysis, density functionality theories, Insilico modeling, synthesis, characterization and biological activities of novel thiazole fused quinazolinone derivatives
Hit, Lead & Candidate Discovery A series of 2‐(2‐substituted benzylidenehydrazinyl‐2‐oxopropyl)‐3‐(4‐[4‐oxo‐2‐phenylthiazolo din‐3‐yl]phenyl)quinazolin‐4(3H)‐one 7a‐7l were synthesized and characterized by IR, 1H‐NMR, 13C‐NMR, mass spectroscopy and elemental analyses. In this present study, the density functionality theory was performed to identify drug stability. Further we introduced graph theoretical analysis by utilised Kyoto Encyclopedia of Genes and Genomes (KEGG) database and Cytoscape software to identify drug target. Based on the observed drug target insilico modeling was executed to know effective drug. The antiepileptic effects of title compounds were evaluated by using MES and subcutaneous pentylenetetrazole (scPTZ) test. Acute neurological toxicity of title compounds was studied by using standardized rotorod test. After 0.5 hr of period many of the compounds showed anticonvulsant activity at MES or scPTZ test. Comparison of the biological activity of test compounds with its chemical structures indicates that, compounds possessing electron donating group exhibited superior activity than the analogs having electron withdrawing moieties. Among the electron donating group tested, amino derivative exhibited good activity than rest of derivatives. From the study it was concluded that, the compound 7j was established as very potent compared with rest of the compounds and standard drugs subjected to biological studies. Thus the compound 2‐(2‐[4‐aminobenzylidene]hydrazinyl‐2‐oxopropyl)‐3‐(4‐[4‐oxo‐2‐phenylthiazolidin‐3‐yl]phenyl) quinazolin‐4(3H)‐one (7j) came out as pilot derivative without any neurotoxicity with a wide spectrum of antiepileptic activity.Highlights: The performed work is having great significance in terms of Graph theoretical analysis used to identify drug target In silico modeling used to identify designed drug interaction with identify target Density functionality studies used to identify synthesized compound energy band gap which is correlate with enhancement of its biological activity Antiepileptic effects of entire synthesized quinazolinone scaffolds were evaluated by MES and scPTZ test 2‐(2‐[4‐aminobenzylidene]hydrazinyl‐2‐oxopropyl)‐3‐(4‐[4‐oxo‐2‐phenylthiazolidin‐3‐yl]phenyl) quinazolin‐4(3H)‐one (7j) was established as very potent compared to the rest of the compounds and standard drugs which were subjected to biological studies
- 23 September 2018
- Published by Wiley in Drug Development Research
- Vol. 79 (6) , 260-274
Design, graph theoretical analysis, density functionality theories, Insilico modeling, synthesis, characterization and biological activities of novel thiazole fused quinazolinone derivatives
Hit, Lead & Candidate Discovery A series of 2‐(2‐substituted benzylidenehydrazinyl‐2‐oxopropyl)‐3‐(4‐[4‐oxo‐2‐phenylthiazolo din‐3‐yl]phenyl)quinazolin‐4(3H)‐one 7a‐7l were synthesized and characterized by IR, 1H‐NMR, 13C‐NMR, mass spectroscopy and elemental analyses. In this present study, the density functionality theory was performed to identify drug stability. Further we introduced graph theoretical analysis by utilised Kyoto Encyclopedia of Genes and Genomes (KEGG) database and Cytoscape software to identify drug target. Based on the observed drug target insilico modeling was executed to know effective drug. The antiepileptic effects of title compounds were evaluated by using MES and subcutaneous pentylenetetrazole (scPTZ) test. Acute neurological toxicity of title compounds was studied by using standardized rotorod test. After 0.5 hr of period many of the compounds showed anticonvulsant activity at MES or scPTZ test. Comparison of the biological activity of test compounds with its chemical structures indicates that, compounds possessing electron donating group exhibited superior activity than the analogs having electron withdrawing moieties. Among the electron donating group tested, amino derivative exhibited good activity than rest of derivatives. From the study it was concluded that, the compound 7j was established as very potent compared with rest of the compounds and standard drugs subjected to biological studies. Thus the compound 2‐(2‐[4‐aminobenzylidene]hydrazinyl‐2‐oxopropyl)‐3‐(4‐[4‐oxo‐2‐phenylthiazolidin‐3‐yl]phenyl) quinazolin‐4(3H)‐one (7j) came out as pilot derivative without any neurotoxicity with a wide spectrum of antiepileptic activity.Highlights: The performed work is having great significance in terms of Graph theoretical analysis used to identify drug target In silico modeling used to identify designed drug interaction with identify target Density functionality studies used to identify synthesized compound energy band gap which is correlate with enhancement of its biological activity Antiepileptic effects of entire synthesized quinazolinone scaffolds were evaluated by MES and scPTZ test 2‐(2‐[4‐aminobenzylidene]hydrazinyl‐2‐oxopropyl)‐3‐(4‐[4‐oxo‐2‐phenylthiazolidin‐3‐yl]phenyl) quinazolin‐4(3H)‐one (7j) was established as very potent compared to the rest of the compounds and standard drugs which were subjected to biological studies
- Top Cited Papers
- 1 May 2018
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 151, 628-685
An overview of quinazolines: Pharmacological significance and recent developments
- 1 May 2018
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 151, 628-685
Top Cited PapersAn overview of quinazolines: Pharmacological significance and recent developments